Dr. Prithviraj Bose, MD

  • Houston, TX
  • Hematologist and oncologist
NPI1154449114PAC ID5597880112
Medicare services, 2024
760
Medicare patients, 2024
187
Part D claims, 2024
147
Publications
187
Clinical trials
3
Practice address
1515 Holcombe Blvd, Houston, TX 77030
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Find Dr. Bose's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Prithviraj Bose is a hematologist and oncologist in Houston, Texas

Dr. Bose practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Bose's NPI, 1154449114, was assigned on March 27, 2007. Dr. Bose graduated from Medical College and Hospital Kolkata in 2002. Dr. Bose's Virginia license number on file is 0101246281.

NPI and contact details
Medicare PAC ID
5597880112
NPI enumeration date
March 27, 2007
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
51
Medical school graduation
2002

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Prithviraj Bose practices at The University of Texas MD Anderson Cancer Center in Houston, Texas

Dr. Bose's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Source: Dmand AI Affiliation Data

Dr. Prithviraj Bose is affiliated with 1 site of care and 1 medical group

Dr. Bose's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Prithviraj Bose's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bose practices. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
The University of Texas MD Anderson Cancer CenterAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Bose practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across The University of Texas System and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Prithviraj Bose is one of 814 hematologists and oncologists in Texas

Hematology and oncology is Dr. Bose's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Bose is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Bose's licenses on file in 12 states: Virginia, Florida, Arizona, Tennessee, Washington, Georgia, Louisiana, Texas, Alabama, Mississippi, Oklahoma and Michigan.

Specialties and state licenses

  • Hematology and oncology, VirginiaPrimaryLicense 0101246281 · 2009 to 2016 · taxonomy 207RH0003X
  • Florida licenseSince 2021
  • Arizona license2022 to 2027
  • Tennessee license2022 to 2027
  • Washington license2022 to 2027
  • Georgia license2022 to 2026
  • Louisiana license2022 to 2026
  • Texas licenseLicense Q2742 · 2015 to 2026
  • Alabama license2023 to 2025
  • Mississippi license2022 to 2025
  • Oklahoma licenseLicense 25431 · 2007 to 2025
  • Internal medicine, MichiganLicense 4301085367 · 2005 to 2007 · taxonomy 207R00000X

Clinical focus

Dmand AI lists anemia, chronic anemia, chronic leukemia, lung cancer, lymphoma and prostate cancer among the conditions Dr. Bose treats.

Hematologists and oncologists near Dr. Bose

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Prithviraj Bose billed Medicare for 760 services in 2024

CMS data shows 760 Medicare services from Dr. Bose across 7 procedure codes in 2024, for 187 Medicare patients. Medicare paid $63,881 for them.

Medicare services, 2024760
Medicare patients187
Paid by Medicare$63,881
Procedure codes7

Dr. Bose's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 8082024: 7606%

Where Dr. Bose's Medicare services took place, 2024

  • In an office203%
  • In a facility74097%

Dr. Bose compared with the Texas median for hematologists and oncologists, 2024

  • Dr. Bose
  • Texas median
Medicare services
760vs 1,16235% below
Medicare patients
187vs 25125% below
Part D claims
49vs 48990% below

Medians across 758 hematologists and oncologists in Texas with Dmand AI profiles that report each measure.

Dr. Bose's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Bose

Need commercial claims for Dr. Bose?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Bose and other hematologists and oncologists in Texas.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Prithviraj Bose treated 187 Medicare patients in 2024, average age 74

CMS counts 187 Medicare patients who saw Dr. Bose in 2024. The largest group is 65 to 74, with 89 patients. 75% of them have high blood pressure, and 72% have high cholesterol. Their average risk score is 2.62, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bose's median patient age at 72, with 49% women.

Medicare patients, 2024187
Average age74
Average risk score2.62

Dr. Bose's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Dr. Bose's Medicare patients by sex, 2024

  • Women8847%
  • Men9953%

Chronic conditions among Dr. Bose's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol72%
  3. Arthritis44%
  4. Chronic kidney disease40%
  5. Ischemic heart disease35%
  6. Diabetes32%
  7. Mood disorders32%
  8. Anxiety28%

Share of Medicare patients with each condition. A patient can have several.

Dr. Bose's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 72

Patient panel by sex, all payers

  • Women49%
  • Men51%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Prithviraj Bose wrote 147 Medicare Part D claims in 2024

In 2024, Dr. Bose wrote 147 Medicare Part D claims for 44 patients. 77% of them were for generic drugs. CMS names the drug for 49 of them, across 3 drugs with 11 or more claims each, at $342,948 in total drug cost. In 2023, CMS named 66 claims across 4 drugs.

Part D claims, 2024147
Drugs named by CMS3
Total drug cost$342,948
Part D patients44

Dr. Bose's Part D claims by kind of drug, 2024

  • Generic113 claims77%
  • Brand-name34 claims23%

Dr. Bose's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Bose's Part D claims, 2024

  • Antibiotics14%21 of 147 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 662024: 4926%

Drugs named by CMS: 3 in 2024, 4 in 2023.

See all prescribing by Dr. Bose

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Prithviraj Bose scored 84 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Bose for performance year 2024, reported as part of a group. Dr. Bose accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bose as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. Bose's MIPS scores, performance year 2024

  • 84of 100Final score
  • 70.8of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities
  • 68of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Bose by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Prithviraj Bose has 187 publications on record

Dmand AI links 187 papers to Dr. Bose, published from 2009 to 2025. 2021 was the busiest year, with 18. The most frequent topics are Primary Myelofibrosis, Leukemia, Myeloid, Acute and Protein Kinase Inhibitors. Dr. Bose has published most often in Clin Lymphoma Myeloma Leuk. Dr. Bose's most frequent co-authors are Naveen Pemmaraju, MD, Srdan Verstovsek, MD, PhD and Hagop M. Kantarjian, MD.

Papers187
Years published2009 to 2025

Dr. Bose's papers by year, 2016 to 2025

Topics Dr. Bose writes about most

  • Primary Myelofibrosis
  • Leukemia, Myeloid, Acute
  • Protein Kinase Inhibitors
  • Antineoplastic Combined Chemotherapy Protocols
  • Pyrimidines
  • Nitriles
  • Pyrazoles
  • Antineoplastic Agents

Dr. Bose's most frequent co-authors

Recent publications by Dr. Bose

See all 187 publications and co-authors

See who Dr. Bose researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Bose works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Prithviraj Bose has worked on 3 clinical trials

Dmand AI links Dr. Bose to 3 clinical trials. Conditions studied include Agranulocytosis, Leukemia, Myeloid, Accelerated Phase and Leukemia, Myeloid, Acute. M.D. Anderson Cancer Center sponsors the most, 2.

Clinical trials with Dr. Bose by phase

  1. 1Phase 1: 1 trial
  2. 1Phase 2: 1 trial
  3. 1Phase 3: 1 trial
  4. NonePhase 4: no trials

Conditions in Dr. Bose's trials

  • Agranulocytosis
  • Leukemia, Myeloid, Accelerated Phase
  • Leukemia, Myeloid, Acute
  • Blast Crisis
  • Leukemia, Myeloid

Investigators on the most trials with Dr. Bose

Recent clinical trials with Dr. Bose

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Prithviraj Bose received $494,199 in industry payments from 2016 to 2025

CMS Open Payments shows 464 general payments to Dr. Bose from 24 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 70% of the total. Incyte Corporation paid the most, $198,766. It also lists 4 research payments totaling $3,518 in 2025.

General payments to Dr. Bose by program year, 2016 to 2025

General payments to Dr. Bose by kind, 2016 to 2025

$494.2Kin total
  • Consulting fees$345,65770%
  • Speaker and faculty fees$60,17012%
  • Travel and lodging$46,1789%
  • Honoraria$25,7005%
  • Other$16,4003%

Companies that paid Dr. Bose the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Bose

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Prithviraj Bose has 4 awards and honors on record

Dmand AI lists 4 awards for Dr. Bose, most recently Physician’s Recognition Award with Commendation in 2011.

Awards and honors for Dr. Bose

  1. 2011
    • Physician’s Recognition Award with Commendation
  2. 1997
    • University Honors
  3. 1995
    • First Certificate of Honors in Biochemistry
  4. Undated
    • Outstanding Researcher

Source: Dmand AI Professional Profile Data

Dr. Prithviraj Bose graduated from Medical College and Hospital Kolkata

Dr. Bose graduated from Medical College and Hospital Kolkata in 2002. Dr. Bose is a member of ASCO.

  1. Medical schoolMedical College and Hospital Kolkata
  2. Board certified in hematologyAmerican Board of Internal Medicine

Source: Dmand AI Professional Profile Data

Dr. Prithviraj Bose accepts plans from 6 insurance carriers

Dr. Bose is in network with 6 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.

  • Aetna
  • Elevance
  • Excellus BlueCross BlueShield
  • Blue Cross Blue Shield of Michigan
  • Blue Cross Blue Shield of Massachusetts
  • CMS Medicare

Plan types Dr. Bose accepts, by number of carriers

  1. Medicare5
  2. PPO5
  3. HMO4
  4. POS4
  5. EPO3

Source: Dmand AI Insurance Network Data

Sources for Dr. Prithviraj Bose's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Awards and committee rolesDmand AI Professional Profile Data
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Prithviraj Bose

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Prithviraj Bose's NPI number?

Dr. Prithviraj Bose's NPI number is 1154449114. It was assigned on March 27, 2007, and it is active in the NPI Registry.

What kind of doctor is Dr. Prithviraj Bose?

Dr. Prithviraj Bose is a hematologist and oncologist in Houston, Texas. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Prithviraj Bose practice?

Dr. Bose practices at 1515 Holcombe Blvd, Houston, TX 77030. Dr. Bose's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

What is Dr. Prithviraj Bose's medical license number?

Dr. Bose's Virginia license number on file is 0101246281, one of the licenses on file in 12 states.

Which states has Dr. Prithviraj Bose been licensed in?

Dmand AI has state licenses on file for Dr. Bose in Virginia (2009 to 2016), Florida (since 2021), Arizona (2022 to 2027), Tennessee (2022 to 2027), Washington (2022 to 2027), Georgia (2022 to 2026), Louisiana (2022 to 2026), Texas (2015 to 2026), Alabama (2023 to 2025), Mississippi (2022 to 2025), Oklahoma (2007 to 2025) and Michigan (2005 to 2007).

Which hospitals is Dr. Prithviraj Bose affiliated with?

Dr. Bose practices at The University of Texas MD Anderson Cancer Center in Houston, Texas.

What medical group is Dr. Prithviraj Bose part of?

Dr. Bose is linked to Physicians Referral Service.

Does Dr. Prithviraj Bose accept Medicare?

Yes. CMS data shows Dr. Bose billed Medicare for 760 services in 2024, and Dr. Bose accepts Medicare assignment.

Does Dr. Prithviraj Bose offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Bose as offering telehealth services.

What is Dr. Prithviraj Bose's MIPS score?

Dr. Bose's MIPS final score for performance year 2024 is 84 out of 100, reported as part of a group.

Show 10 more questionsShow fewer questions

How many Medicare patients does Dr. Prithviraj Bose see?

CMS counts 187 Medicare patients who saw Dr. Bose in 2024, with an average age of 74.

Is Dr. Prithviraj Bose board certified?

Yes. Dr. Bose is board certified in hematology by the American Board of Internal Medicine.

What services does Dr. Prithviraj Bose bill to Medicare?

In 2024, Dr. Bose's most billed Medicare services were office visit, established patient (99214), hospital inpatient care (99233) and office visit, established patient (99215).

Where did Dr. Prithviraj Bose go to medical school?

Dr. Bose graduated from Medical College and Hospital Kolkata in 2002.

What drugs does Dr. Prithviraj Bose prescribe most?

In 2024 Medicare Part D data, Dr. Bose's most prescribed drugs by claims were Jakafi, Valacyclovir and Levofloxacin.

Has Dr. Prithviraj Bose received payments from drug or device companies?

CMS Open Payments shows $494,199 in general payments to Dr. Bose from 24 companies from 2016 to 2025. The largest total came from Incyte Corporation.

How long has Dr. Prithviraj Bose been practicing?

Dr. Bose graduated from medical school in 2002, 24 years ago.

Does Dr. Prithviraj Bose do research?

Dmand AI links 187 publications to Dr. Bose, published from 2009 to 2025. Dr. Bose has worked on 3 clinical trials.

Who does Dr. Prithviraj Bose publish with?

Dr. Bose's most frequent co-authors are Naveen Pemmaraju, MD (54 shared papers), Srdan Verstovsek, MD, PhD (54 shared papers) and Hagop M. Kantarjian, MD (50 shared papers).

What insurance does Dr. Prithviraj Bose accept?

Dr. Bose is in network with 6 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.

Selling to hematology and oncology practices?

See hematologists and oncologists in Texas by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)